Health October 9, 2024Healthy Returns: Pfizer pulls Sickle Cell Disease drug from markets – here’s why it matters The pharmaceutical giant last week announced it would voluntarily withdraw its sickle cell disease therapy, Oxbryta, from worldwide markets — to the surprise of doctors, patients and investors.
